Literature DB >> 1308938

Human immune responses during schistosomiasis mansoni.

G Gazzinelli1, D G Colley.   

Abstract

Studies of immune responses as they occur in patients with schistosomiasis appear to progress relative to cUrrent technological advances, and to advance despite the understandable inability to pursue in vivo manipulations in this host/parasite system. Emphasis is most often placed on making immunological comparisons between such patient groups as reinfected/non-reinfected, intestinal/hepatosplenic, high/low intensities of infection, infected/uninfected within endemic areas, and those born of infected/uninfected mothers. Based on these types of comparisons, reasonable conjectures can be made regarding the immunological occurrences during this chronic exposure condition. Some consideration is now being given to the immune mechanisms of some of the observations made, and while some of these must then be carried back to experimental models for further manipulation-based analysis, new technological developments continue to assist in the field/bench ability to ask questions that might assist our understanding to a point where this knowledge can be applied to shaping developmental approaches to vaccine development and the goal of alleviating morbidity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1308938     DOI: 10.1590/s0037-86821992000200006

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  5 in total

1.  Factors associated with resistance to Schistosoma mansoni infection in an endemic area of Bahia, Brazil.

Authors:  Ricardo R Oliveira; Joanemile P Figueiredo; Luciana S Cardoso; Rafael L Jabar; Robson P Souza; Martin T Wells; Edgar M Carvalho; Daniel W Fitzgerald; Kathleen C Barnes; Maria Ilma Araújo; Marshall J Glesby
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice.

Authors:  Kameshwar P Singh; Herve C Gerard; Alan P Hudson; Thipparthi R Reddy; Dov L Boros
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

3.  Profile of T and B lymphocytes in individuals resistant to Schistosoma mansoni infection.

Authors:  Robson da Paixão de Souza; Maria Ilma Araújo; Diego Mota Lopes; Sérgio Costa Oliveira; Jamille Souza Fernandes; Kelvin Edson M de Jesus; Edgar M Carvalho; Ricardo Riccio Oliveira; Luciana Santos Cardoso
Journal:  Parasitol Res       Date:  2022-02-08       Impact factor: 2.289

4.  Cytokine profile, proliferation and phosphorylation of ERK1/2 and Akt in circulating mononuclear cells from individuals during the chronic intestinal phase of Schistosomiasis mansoni infection.

Authors:  Roberta Oliveira-Prado; Iramaya Rodrigues Caldas; Andréa Teixeira-Carvalho; Marcus Vinicius Andrade; Rafaelle Christine Gomes Fares; Laís Maroni Portugal; Andréa Gazzinelli; Rodrigo Corrêa-Oliveira; José Renan Cunha-Melo
Journal:  BMC Infect Dis       Date:  2012-12-27       Impact factor: 3.090

5.  An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum.

Authors:  Xin Long; Qian Chen; Jianping Zhao; Nicholas Rafaels; Priyanka Mathias; Huifang Liang; Joseph Potee; Monica Campbell; Bixiang Zhang; Li Gao; Steve N Georas; Donata Vercelli; Terri H Beaty; Ingo Ruczinski; Rasika Mathias; Kathleen C Barnes; Xiaoping Chen
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.